But the timing for administering the treatment is key, say doctorsMonoclonal antibody treatment is now seen as a relatively effective and safer alternative in treating COVID-19 patients, with doctors stating that, as with any other drug, timing is very important for the administration of the therapy that’s touted as a game changer. “Monoclonal antibody treatment isn’t a one-size-fits-all therapy. “Monoclonal antibody treatment could prove to be a game changer in times to come if used at the appropriate time. The doctor added that monoclonal antibody therapy cost ₹60,000-70,000 and significantly reduced hospital stay. Meanwhile, speaking about making monoclonal antibody treatment available across India, a senior Health Ministry official noted that the Central government had set-up a committee to look at new information on the COVID-19 virus from around the world.

Source: The Hindu June 12, 2021 15:49 UTC